Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?

Prostate Cancer Prostatic Dis. 2022 Apr;25(4):797. doi: 10.1038/s41391-021-00474-6. Epub 2021 Nov 22.

Authors

Irene Caramella¹, Alberto Dalla Volta², Francesca Valcamonico¹, Salvatore Grisanti¹, Alfredo Berruti¹

Affiliations

¹ Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
² Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy. alberto.dallavolta@gmail.com.

PMID: 34811500
DOI: 10.1038/s41391-021-00474-6

No abstract available

Publication types

Letter

MeSH terms

Body Mass Index
Humans
Male
Prognosis
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / pathology

Substances

Prostate-Specific Antigen